Is QuantumScape a Buy Now?
QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…
Sell
33
BIO Quote, Financials, Valuation and Earnings
Last price:
$240.51
Seasonality move
:
5.62%
Day range:
$237.97 - $244.24
52-week range:
$215.38 - $387.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.68x
P/B ratio:
1.04x
Volume:
306.8K
Avg. volume:
399.2K
1-year change:
-9.52%
Market cap:
$6.8B
Revenue:
$2.6B
EPS (TTM):
-$65.04
BIO Analysts' Consensus Rating
The 5 analysts providing 12-month price projections for Bio-Rad Laboratories shares anticipate an average target of $353.17, ranging from a low estimate of $270.00 to a high estimate of $409.00. This average target implies a growth of 44.69% compared to the current stock price of $244.08.
Consensus Price Target
$353.17
Highest Price Target
$409.00
Lowest Price Target
$270.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 2 | 2 | 3 |
| Hold | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | Leans Bullish | Buy |
BIO Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
50
RGC alert for May 1
Regencell Bioscience Holdings [RGC] is up 20.58% over the past day.
Sell
38
WGS alert for May 1
GeneDx Holdings [WGS] is down 6.85% over the past day.
Sell
43
VICR alert for May 1
Vicor [VICR] is down 1.28% over the past day.
